Camptocormia (bent spine syndrome, cyphose hystérique) is an abnormality characterized by severe forward flexion of the thoracolumbar spine which typically increases during walking or standing and completely disappears in supine position. Camptocormia can be due to central nervous system diseases, such as Parkinson’s disease, dystonia, multisystem atrophy, or Alzheimer’s disease, due to peripheral nervous system diseases, such as primary myopathy, secondary myopathy, motor neuron disease, myasthenia, or chronic inflammatory demyelinating polyneuropathy, due to side effects of drug treatment, due to disc herniation, arthritis or spinal trauma, or due to paraneoplasia. Only rarely may camptocormia be attributable to psychiatric disease. The diagnosis is based on clinical findings, imaging of the cerebrum or spine, needle electromyography, or muscle biopsy. Treatment options are limited and frequently futile and rely on conservative measures, such as psychotherapy, physiotherapy, use of orthoses, drugs, injection of botulinum toxin, withdrawal of causative drugs, electroconvulsive therapy, or invasive measures, such as surgical correction or deep brain stimulation. The outcome is generally fair. Some patients profit from therapy whereas others do not respond to treatment and become progressively immobile.

Keywords:
Movement disorder, Neuromuscular disease, Spinal deformity, Muscle disease, Parkinson, Dystonia
1.
Margraf NG, Wrede A, Rohr A, Schulz-Schaeffer WJ, Raethjen J, Eymess A, Volkmann J, Mehdorn MH, Jansen O, Deuschl G: Camptocormia in idiopathic Parkinson’s disease: a focal myopathy of the paravertebral muscles. Mov Disord 2010;25:542–551.
2.
Sławek J, Derejko M, Lass P, Dubaniewicz M: Camptocormia or Pisa syndrome in multiple system atrophy. Clin Neurol Neurosurg 2006;108:699–704.
3.
Bloch F, Houeto JL, Tezenas du Montcel S, Bonneville F, Etchepare F, Welter ML, Rivaud-Pechoux S, Hahn-Barma V, Maisonobe T, Behar C, Lazennec JY, Kurys E, Arnulf I, Bonnet AM, Agid Y: Parkinson’s disease with camptocormia. J Neurol Neurosurg Psychiatry 2006;77:1223–1228.
4.
De Sèze MP, Creuzé A, de Sèze M, Mazaux JM: An orthosis and physiotherapy programme for camptocormia: a prospective case study. J Rehabil Med 2008;40:761–765.
5.
Brodie BC: Pathological and Surgical Observations on the Disease of the Joints. London, Longman, 1818, p 276.
6.
Brodie BC: Lecture illustrative of certain local nervous affections. London, Longman, 1837; cited according to Hawkins C: The Works of Sir Benjamin Collins Brodie, vol 3. London, Longman, 1865, p 164.
7.
Shinjo SK, Torres SC, Radu AS: Camptocormia: a rare axial myopathy disease. Clinics (São Paulo) 2008;63:416–417.
8.
Karbowski K: The old and the new camptocormia. Spine (Phila Pa 1976) 1999;24:1494–1498.
9.
Souques A, Rosanoff-Saloff M: La camptocormie. Incurvation du tronc consécutive aux traumatismes du dos et des lombes. Considérations morphologiques. Société de neurologie de Paris, seance du 4 novembre 1915. Rev Neurol 1914–1915, pp 937–939.
10.
Southard EE: Shell-Shock and Other Neuropsychiatric Problems Presented in 589 Case Histories from the War Literature, 1914–1918. Boston, Leonard, 1919.
11.
Macleod AD: Head drop and camptocormia. J Neurol Neurosurg Psychiatry 2003;74:692.
12.
Djaldetti R, Mosberg-Galili R, Sroka H, Merims D, Melamed E: camptocormia (bent spine) in patients with Parkinson’s disease – characterization and possible pathogenesis of an unusual phenomenon. Mov Disord 1999;14:443–447.
13.
Serratrice G: Clinical semiology of neuromuscular diseases. Bent spine myopathy or syndrome. Acta Myol 2007;26:1–4.
14.
Reichel G, Kirchhöfer U, Stenner A: camptocormia – segmental dystonia. Proposal of a new definition for an old disease. Nervenarzt 2001;72:281–285.
15.
Tiple D, Fabbrini G, Colosimo C, Ottaviani D, Camerota F, Defazio G, Berardelli A: camptocormia in Parkinson disease: an epidemiological and clinical study. J Neurol Neurosurg Psychiatry 2009;80:145–148.
16.
Kocaaga Z, Bal S, Turan Y, Gurgan A, Esmeli F: camptocormia and dropped head syndrome as a clinic picture of myotonic myopathy. Joint Bone Spine 2008;75:730–733.
17.
Diaz-Guzman J, Nunez-Enamorado N, Ruiz-Jimenez J, Garcia E, Diez-Torres I, Ricoy-Campo JR: Parkinsonism and camptocormia with focal spinal myopathy: case report and responsiveness to treatment. Rev Neurol 2006;43:466–469.
18.
Kuo SH, Vullaganti M, Jimenez-Shahed J, Kwan JY: Camptocormia as a presentation of generalized inflammatory myopathy. Muscle Nerve 2009;40:1059–1063.
19.
Melamed E, Djaldetti R: Camptocormia in Parkinson’s disease. J Neurol 2006;253(suppl 7):VII14–VII16.
20.
Ozer F, Ozturk O, Meral H, Serdaroglu P, Yayla V: camptocormia in a patient with Parkinson disease and a myopathy with nemaline rods. Am J Phys Med Rehabil 2007;86:3–6.
21.
Dupeyron A, Stober N, Gelis A, Castelnovo G, Labauge P, Pélissier J: Painful camptocormia: the relevance of shaking your patient’s hand. Eur Spine J 2009 (in press).
22.
Lepoutre AC, Devos D, Blanchard-Dauphin A, Pardessus V, Maurage CA, Ferriby D, Hurtevent JF, Cotten A, Destée A, Defebvre L: A specific clinical pattern of camptocormia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2006;77:1229–1234.
23.
Ricq G, Laroche M: Acquired lumbar kyphosis caused in adults by primary paraspinal myopathy. Epidemiology, computed tomography findings, and outcomes in a cohort of 23 patients. Joint Bone Spine 2000;67:528–532.
24.
Seror P, Krahn M, Laforet P, Leturcq F, Maisonobe T: Complete fatty degeneration of lumbar erector spinae muscles caused by a primary dysferlinopathy. Muscle Nerve 2008;37:410–414.
25.
Dominick J, Sheean G, Schleimer J, Wixom C: Response of the dropped head/bent spine syndrome to treatment with intravenous immunoglobulin. Muscle Nerve 2006;33:824–826.
26.
Umapathi T, Chaudhry V, Cornblath D, Drachman D, Griffin J, Kuncl R: Head drop and camptocormia. J Neurol Neurosurg Psychiatry 2002;73:1–7.
27.
Djaldetti R, Melamed E: Camptocormia in Parkinson’s disease: new insights. J Neurol Neurosurg Psychiatry 2006;77:1205.
28.
Azher SN, Jankovic J: camptocormia: pathogenesis, classification, and response to therapy. Neurology 2005;65:355–359.
29.
Skidmore F, Anderson K, Fram D, Weiner W: Psychogenic camptocormia. Mov Disord 2007;22:1974–1975.
30.
Bouzgarou E, Dupeyron A, Castelnovo G, Boudousq V, Collombier L, Labauge P, Pélissier J: Camptocormia disclosing Parkinson’s disease. Ann Readapt Med Phys 2007;50:55–59.
31.
Spuler S, Krug H, Klein C, Medialdea IC, Jakob W, Ebersbach G, Gruber D, Hoffmann KT, Trottenberg T, Kupsch A: Myopathy causing camptocormia in idiopathic Parkinson’s disease: a multidisciplinary approach. Mov Disord 2010;25:552–559.
32.
Lavault S, Bloch F, Houeto JL, Konofal E, Welter ML, Agid Y, Arnulf I: Periodic leg movements and REM sleep without atonia in Parkinson’s disease with camptocormia. Mov Disord 2009;24:2419–2423.
33.
Schäbitz WR, Glatz K, Schuhan C, Sommer C, Berger C, Schwaninger M, Hartmann M, Hilmar Goebel H, Meinck HM: Severe forward flexion of the trunk in Parkinson’s disease: focal myopathy of the paraspinal muscles mimicking camptocormia. Mov Disord 2003;18:408–414.
34.
Colosimo C, Salvatori FM: Injection of the iliopsoas muscle with botulinum toxin in camptocormia. Mov Disord 2009;24:316–317.
35.
Takei A, Hamada S, Homma S, Hamada K, Tashiro K, Hamada T: Amelioration of subacute camptocormia in multiple system atrophy by protirelin tartrate. Mov Disord 2009;24:2022–2023.
36.
Brucki S, Nitrini R: camptocormia in Alzheimer’s disease: an association? Mov Disord 2008;23:156–157.
37.
Fukaya C, Otaka T, Obuchi T, Kano T, Nagaoka T, Kobayashi K, Oshima H, Yamamoto T, Katayama Y: Pallidal high-frequency deep brain stimulation for camptocormia: an experience of three cases. Acta Neurochir Suppl 2006;99:25–28.
38.
Mahjneh I, Edström B, Sandström G: Bent spine straightens up – a case of camptocormia. Duodecim 2009;125:1889–1893.
39.
Serratrice J, Weiller PJ, Pouget J, Serratrice G: An unrecognized cause of camptocormia: proximal myotonic myopathy. Presse Med 2000;29:1121–1123.
40.
Delcey V, Hachulla E, Michon-Pasturel U, Queyrel V, Hatron PY, Boutry N, Lemaitre V, Vanhille P, Serratrice J, Disdier P, Juhan V, Devulder B, Thévenon A: Camptocormia: a sign of axial myopathy. Report of 7 cases. Rev Med Interne 2002;23:144–154.
41.
Nemitz N, Van Linthoudt D: What is your diagnosis? Camptocormia caused by chronic axial myositis. Praxis (Bern 1994) 2007;96:1714–1716.
42.
Gómez-Puerta JA, Peris P, Grau JM, Martinez MA, Guañabens N: Camptocormia as a clinical manifestation of mitochondrial myopathy. Clin Rheumatol 2007;26:1017–1019.
43.
Kim JM, Song EJ, Seo JS, Nam EJ, Kang YM: Polymyositis-like syndrome caused by hypothyroidism, presenting as camptocormia. Rheumatol Int 2009;29:339–342.
44.
Hachulla E: Dermatomyositis and polymyositis: clinical aspects and treatment. Ann Med Interne (Paris) 2001;152:455–464.
45.
Diederich NJ, Goebel HH, Dooms G, Bumb A, Huber F, Kompoliti K, Meinck HM: Camptocormia associated with focal myositis in multiple-system atrophy. Mov Disord 2006;21:390–394.
46.
Charpentier P, Dauphin A, Stojkovic T, Cotten A, Hurtevent JF, Maurage CA, Thévenon A, Destée A, Defebvre L: Parkinson’s disease, progressive lumbar kyphosis and focal paraspinal myositis. Rev Neurol (Paris) 2005;161:459–463.
47.
Wakata N, Konno S, Nomoto N, Sugimoto H, Nemoto H, Kurihara T, Kishi M: Myasthenia gravis with concomitant severe paraspinal muscle degeneration and mitochondrial DNA4977 deletion. Intern Med 2007;46:747–750.
48.
McCluskey LF: Camptocormia: pathogenesis, classification, and response to therapy. Neurology 2006;66:1285–1286.
49.
Laroche M, Ricq G, Delisle MB, Campech M, Marque P: Bent spine syndrome: computed tomographic study and isokinetic evaluation. Muscle Nerve 2002;25:189–193.
50.
Gautier G, Verschueren A, Monnier A, Attarian S, Salort-Campana E, Pouget J: ALS with respiratory onset: clinical features and effects of non-invasive ventilation on the prognosis. Amyotroph Lateral Scler 2010 (in press).
51.
Terashima M, Kataoka H, Sugie K, Horikawa H, Ueno S: Coexistence of chronic inflammatory demyelinating polyneuropathy and camptocormia. J Neurol Neurosurg Psychiatry 2009;80:1296–1297.
52.
Duman I, Baklaci K, Tan AK, Kalyon TA: Unusual case of camptocormia triggered by lumbar-disc herniation. Clin Rheumatol 2008;27:525–527.
53.
Jungbluth H, Lillis S, Zhou H, Abbs S, Sewry C, Swash M, Muntoni F: Late-onset axial myopathy with cores due to a novel heterozygous dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscul Disord 2009;19:344–347.
54.
Inzelberg R, Hattori N, Nisipeanu P, Abo Mouch S, Blumen SC, Carasso RL, Mizuno Y: Camptocormia, axial dystonia, and parkinsonism: phenotypic heterogeneity of a parkin mutation. Neurology 2003;60:1393–1394.
55.
Vela L, Jiménez Morón D, Sánchez C, Pareja JA, Barón M: Camptocormia induced by atypical antipsychotics and resolved by electroconvulsive therapy. Mov Disord 2006;21:1977–1980.
56.
Micheli F, Pardal MM: DOPA-responsive dystonic camptocormia. Neurology 2007;68:1543.
57.
Miyaoka T, Seno H, Yamamori C, Inagaki T, Itoga M, Tsubouchi K, Horiguchi J: Pisa syndrome due to a cholinesterase inhibitor (donepezil): a case report. J Clin Psychiatry 2001;62:573–574.
58.
Yohanan M, Aulakh JS, Weith J, Hawkins JW: Pisa syndrome in a patient in a wheelchair taking valproic acid. Am J Psychiatry 2006;163:325–326.
59.
Shuper A, Keller A, Arbel N, Inbar D, Steinberg T: Trauma-induced dystonia and camptocormia in a child. Pediatr Neurol 2007;36:184–185.
60.
Skidmore F, Mikolenko I, Weiss H, Weiner W: Camptocormia in a patient with multiple system atrophy. Mov Disord 2005;20:1063–1064.
61.
Zwecker M, Iancu I, Zeilig G, Ohry A: Camptocormia: a case of possible paraneoplastic aetiology. Clin Rehabil 1998;12:157–160.
62.
Rosen JC, Frymoyer JW: A review of camptocormai and an unusual case in the female. Spine (Phila Pa 1976) 1985;10:325–327.
63.
Miller RW, Forbes JF: Camptocormia. Mil Med 1990;155:561–565.
64.
Rajmohan V, Thomas B, Sreekumar K: Case study: camptocormia, a rare conversion disorder. J Am Acad Child Adolesc Psychiatry 2004;43:1168–1170.
65.
Gomez EA, Drooby AS: Camptocormia in a case of manic-depressive disorder. Psychosomatics 1987;28:592, 594–595.
66.
Haig AJ, Tong HC, Kendall R: The bent spine syndrome: myopathy + biomechanics = symptoms. Spine J 2006;6:190–194.
67.
Laroche M, Delisle MB, Aziza R, Lagarrigue J, Mazieres B: Is camptocormia a primary muscular disease? Spine (Phila Pa 1976) 1995;20:1011–1016.
68.
Delisle MB, Laroche M, Dupont H, Rochaix P, Rumeau JL: Morphological analyses of paraspinal muscles: comparison of progressive lumbar kyphosis (camptocormia) and narrowing of lumbar canal by disc protrusions. Neuromuscul Disord 1993;3:579–582.
69.
Hilliquin P, Menkès CJ, Laoussadi S, Job-Deslandre C, Serratrice G: Camptocormia in the elderly. A new entity by paravertebral muscle involvement? Rev Rhum Mal Osteoartic 1992;59:169–175.
70.
Gdynia HJ, Sperfeld AD, Unrath A, Ludolph AC, Sabolek M, Storch A, Kassubek J: Histopathological analysis of skeletal muscle in patients with Parkinson’s disease and ‘dropped head’/’bent spine’ syndrome. Parkinsonism Relat Disord 2009;15:633–639.
71.
Abdulhadi HM, Kerrigan DC: Camptocormia: a biomechanical analysis. A case report. Am J Phys Med Rehabil 1996;75:310–313.
72.
Von Coelln R, Raible A, Gasser T, Asmus F: Ultrasound-guided injection of the iliopsoas muscle with botulinum toxin in camptocormia. Mov Disord 2008;23:889–892.
73.
Pardessus V, Compere S, Tiffreau V, Blanchard A, Thevenon A: Leather corset for the treatment of camptocormia: 31 cases. Ann Readapt Med Phys 2005;48:603–609.
74.
Song IU, Kim JS, Lee KS: DOPA-responsive camptocormia in a patient with multiple system atrophy. Parkinsonism Relat Disord 2008;14:161–163.
75.
Van Gerpen JA: DOPA-responsive dystonic camptocormia. Neurology 2006;66:1779.
76.
Ho B, Prakash R, Morgan JC, Sethi KD: A case of levodopa-responsive camptocormia associated with advanced Parkinson’s disease. Nat Clin Pract Neurol 2007;3:526–530.
77.
Fietzek UM, Schroeteler FE, Ceballos-Baumann AO: Goal attainment after treatment of parkinsonian camptocormia with botulinum toxin. Mov Disord 2009;24:2027–2028.
78.
Fukaya C, Otaka T, Obuchi T, Kano T, Nagaoka T, Kobayashi K, Oshima H, Yamamoto T, Katayama Y: Pallidal high-frequency deep brain stimulation for camptocormia: an experience of three cases. Acta Neurochir Suppl 2006;99:25–28.
79.
Hellmann MA, Djaldetti R, Israel Z, Melamed E: Effect of deep brain subthalamic stimulation on camptocormia and postural abnormalities in idiopathic Parkinson’s disease. Mov Disord 2006;21:2008–2010.
80.
Umemura A, Oka Y, Ohkita K, Yamawaki T, Yamada K: Effect of subthalamic deep brain stimulation on postural abnormality in Parkinson disease. J Neurosurg 2009 (in press).
81.
Yamada K, Goto S, Matsuzaki K, Tamura T, Murase N, Shimazu H, Nagahiro S, Kuratsu J, Kaji R: Alleviation of camptocormia by bilateral subthalamic nucleus stimulation in a patient with Parkinson’s disease. Parkinsonism Relat Disord 2006;12:372–375.
82.
Nandi D, Parkin S, Scott R, Winter JL, Joint C, Gregory R, Stein J, Aziz TZ: Camptocormia treated with bilateral pallidal stimulation: case report. Neurosurg Focus 2002;12:ECP2.
83.
Peek AC, Quinn N, Casey AT, Etherington G: Thoracolumbar spinal fixation for camptocormia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2009;80:1275–1278.
84.
Oerlemans WG, de Visser M: Dropped head syndrome and bent spine syndrome: two separate clinical entities or different manifestations of axial myopathy? J Neurol Neurosurg Psychiatry 1998;65:258–259.
85.
Windpassinger C, Schoser B, Straub V, Hochmeister S, Noor A, Lohberger B, Farra N, Petek E, Schwarzbraun T, Ofner L, Löscher WN, Wagner K, Lochmüller H, Vincent JB, Quasthoff S: An X-linked myopathy with postural muscle atrophy and generalized hypertrophy, termed XMPMA, is caused by mutations in FHL1. Am J Hum Genet 2008;82:88–99.
86.
Salazar Z, Tschopp L, Calandra C, Micheli F: Pisa syndrome and parkinsonism secondary to valproic acid in Huntington’s disease. Mov Disord 2008;23:2430–2431.
87.
Gerton BK, Theeler B, Samii A: Backpack treatment for camptocormia. Mov Disord 2010;25:247–248.
88.
Sako W, Nishio M, Maruo T, Shimazu H, Matsuzaki K, Tamura T, Mure H, Ushio Y, Nagahiro S, Kaji R, Goto S: Subthalamic nucleus deep brain stimulation for camptocormia associated with Parkinson’s disease. Mov Disord 2009;24:1076–1079.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.